Cargando…
The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis
We conducted the present study to investigate the therapeutic effects of propranolol (PRO), alone and in combination with the antiresorptive agent ZOL, in a rat model of postmenopausal osteoporosis. Female Wistar rats were OVX or sham-operated at 3 months of age. Twelve weeks after surgery, rats wer...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988934/ https://www.ncbi.nlm.nih.gov/pubmed/24800099 http://dx.doi.org/10.1155/2014/586431 |
_version_ | 1782312091748663296 |
---|---|
author | Khajuria, Deepak Kumar Razdan, Rema Mahapatra, D. Roy |
author_facet | Khajuria, Deepak Kumar Razdan, Rema Mahapatra, D. Roy |
author_sort | Khajuria, Deepak Kumar |
collection | PubMed |
description | We conducted the present study to investigate the therapeutic effects of propranolol (PRO), alone and in combination with the antiresorptive agent ZOL, in a rat model of postmenopausal osteoporosis. Female Wistar rats were OVX or sham-operated at 3 months of age. Twelve weeks after surgery, rats were randomized into six groups: (1) sham + vehicle, (2) OVX + vehicle, (3) OVX + ZOL (100 μg/kg, i.v. single dose), (4) OVX + ZOL (50 μg/kg, i.v. single dose), (5) OVX + PRO (0.1 mg/kg, s.c. 5 days per week), and (6) OVX + ZOL (50 μg/kg, i.v. single dose) + PRO (0.1 mg/kg, s.c. 5 days per week) for 12 weeks. At the end of treatment study, various bone parameters were evaluated. With respect to improvement in the mechanical strength of the lumbar spine and the femoral mid-shaft, the combination treatment of ZOL and PRO was more effective than each drug administered as a monotherapy. Moreover, combination therapy using ZOL and PRO preserved the trabecular microarchitecture better than single-drug therapy using ZOL or PRO in OVX rats. These data suggest that combination therapy with ZOL plus PRO represents a potentially useful therapeutic option for patients with osteoporosis. |
format | Online Article Text |
id | pubmed-3988934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-39889342014-05-05 The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis Khajuria, Deepak Kumar Razdan, Rema Mahapatra, D. Roy J Osteoporos Research Article We conducted the present study to investigate the therapeutic effects of propranolol (PRO), alone and in combination with the antiresorptive agent ZOL, in a rat model of postmenopausal osteoporosis. Female Wistar rats were OVX or sham-operated at 3 months of age. Twelve weeks after surgery, rats were randomized into six groups: (1) sham + vehicle, (2) OVX + vehicle, (3) OVX + ZOL (100 μg/kg, i.v. single dose), (4) OVX + ZOL (50 μg/kg, i.v. single dose), (5) OVX + PRO (0.1 mg/kg, s.c. 5 days per week), and (6) OVX + ZOL (50 μg/kg, i.v. single dose) + PRO (0.1 mg/kg, s.c. 5 days per week) for 12 weeks. At the end of treatment study, various bone parameters were evaluated. With respect to improvement in the mechanical strength of the lumbar spine and the femoral mid-shaft, the combination treatment of ZOL and PRO was more effective than each drug administered as a monotherapy. Moreover, combination therapy using ZOL and PRO preserved the trabecular microarchitecture better than single-drug therapy using ZOL or PRO in OVX rats. These data suggest that combination therapy with ZOL plus PRO represents a potentially useful therapeutic option for patients with osteoporosis. Hindawi Publishing Corporation 2014 2014-03-30 /pmc/articles/PMC3988934/ /pubmed/24800099 http://dx.doi.org/10.1155/2014/586431 Text en Copyright © 2014 Deepak Kumar Khajuria et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Khajuria, Deepak Kumar Razdan, Rema Mahapatra, D. Roy The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis |
title | The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis |
title_full | The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis |
title_fullStr | The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis |
title_full_unstemmed | The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis |
title_short | The Combination Therapy with Zoledronic Acid and Propranolol Improves the Trabecular Microarchitecture and Mechanical Property in an Rat Model of Postmenopausal Osteoporosis |
title_sort | combination therapy with zoledronic acid and propranolol improves the trabecular microarchitecture and mechanical property in an rat model of postmenopausal osteoporosis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988934/ https://www.ncbi.nlm.nih.gov/pubmed/24800099 http://dx.doi.org/10.1155/2014/586431 |
work_keys_str_mv | AT khajuriadeepakkumar thecombinationtherapywithzoledronicacidandpropranololimprovesthetrabecularmicroarchitectureandmechanicalpropertyinanratmodelofpostmenopausalosteoporosis AT razdanrema thecombinationtherapywithzoledronicacidandpropranololimprovesthetrabecularmicroarchitectureandmechanicalpropertyinanratmodelofpostmenopausalosteoporosis AT mahapatradroy thecombinationtherapywithzoledronicacidandpropranololimprovesthetrabecularmicroarchitectureandmechanicalpropertyinanratmodelofpostmenopausalosteoporosis AT khajuriadeepakkumar combinationtherapywithzoledronicacidandpropranololimprovesthetrabecularmicroarchitectureandmechanicalpropertyinanratmodelofpostmenopausalosteoporosis AT razdanrema combinationtherapywithzoledronicacidandpropranololimprovesthetrabecularmicroarchitectureandmechanicalpropertyinanratmodelofpostmenopausalosteoporosis AT mahapatradroy combinationtherapywithzoledronicacidandpropranololimprovesthetrabecularmicroarchitectureandmechanicalpropertyinanratmodelofpostmenopausalosteoporosis |